Home » Newsletters » BioWorld Science

BioWorld Science

May 18, 2005

View Archived Issues

Astressin-2B reduces enterotoxin-mediated inflammatory processes

SLV-317 exerts antiinflammatory effects in experimental ileitis and colitis

Chugai reports domestic and overseas progress

Updated results for Genasense in CLL

Animal data on SP-304

Bionomics receives grant extension for CNS drug development

Talotrexin enters new phase I/II study for ALL

New phase Ib/II study of ADH-1

Mera and Rincon announce protein expression system research collaboration

Sorafenib plus chemotherapy studied in new phase III trial

Low incidence of anemia found with viramidine plus peginterferon alfa-2a in hepatitis C patients

Good safety profile found for multiple doses of VX-950 in healthy subjects

New data on the safety and pharmacokinetics of CpG-10101 in hepatitis C

SCR-011, a therapeutic candidate for ocular neovascularization

MB-500 promotes corneal wound healing

Antisense hTERT shows potential as a gastric cancer therapy

Amarillo receives SBIR grant for H. pylori vaccine development work

New stem cell trial to begin in heart failure patients

Piperazine derivative shows anxiolytic and antidepressant activity in preclinical studies

Novel benzodiazepine derivatives possess prolonged anticonvulsant properties

Recent patents disclose novel therapeutic agents for cancer

Remicade approved for psoriatic arthritis

Traditional approval for Trizivir

Novel SERMs emerge from GlaxoSmithKline research

Vertex patents voltage-gated sodium channel inhibitors for treatment of pain

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...